BRIEF-Sino Biopharmaceutical Says Unit's "Apixaban Tablet" Got Drug Registration Approval In PRC

May 22 (Reuters) - Sino Biopharmaceutical Ltd:

* UNIT'S APIXABAN TABLET GETS APPROVAL FOR DRUG REGISTRATION BY NATIONAL MEDICAL PRODUCTS ADMINISTRATION OF PRC Source text for Eikon: Further company coverage: (Reuters.Briefs@thomsonreuters.com)

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting